Rimonabant
| CAS No. | 168273-06-1 | Cat. No. | BCP07803 |
| Name | Rimonabant | ||
| Synonyms | SR141716;SR 141716;SR-141716; A 281; A-281; A281; | ||
| Formula | C22H21Cl3N4O | M. Wt | 463.79 |
| Description | Rimonabant, also known as SR141716 and A 281, is an anorectic anti-obesity drug. It is an inverse agonist for the cannabinoid receptor CB1. Its main avenue of effect is reduction in appetite. Rimonabant is the first selective CB1 receptor blocker to be approved for use anywhere in the world. Rimonabant is approved in 38 countries including the E.U., Mexico, and Brazil. It was rejected for approval for use in the United States. | ||
| Pathways | GPCR/G Protein | ||
| Targets | Cannabinoid Receptor | ||
Structure
Part data of this page collected from the open network resources, so Biochempartner can not guarantee its accuracy.
For product details of different batches, please contact our Customer
- Service & Tech Support:orders@biochempartner.com
- Website:www.biochempartner.com
Products are for research use only and not for human use. We do not sell to patients.